Key Takeaways
- US-China trade tensions are escalating, with a U.S. Treasury official calling China's negotiator "disrespectful" and "Unhinged," while China imposes sanctions on a South Korean firm linked to the U.S.
- Tariffs are projected to cost U.S. firms a staggering $1.2 trillion in 2025, with the majority of this financial burden expected to be passed directly to consumers.
- Federal Reserve officials, particularly Neel Kashkari, are navigating a "tricky situation" amidst persistent inflation concerns and the challenge of interpreting economic signals due to a government shutdown, while firmly asserting the Fed's independence.
- Pharmaceutical giants Eli Lilly (LLY) and Novo Nordisk (NVO) experienced a decline in share prices after former President Trump indicated that the price of the blockbuster diabetes drug Ozempic could be reduced to just $150 a month.
- Gold and silver have surged to all-time highs, driven by growing fears about credit quality within the economy and heightened US-China frictions, reinforcing their role as safe-haven assets.
US-China Trade Tensions Intensify, Tariffs Loom Large
Geopolitical tensions between the U.S. and China are reaching a fever pitch, with U.S. Treasury Secretary Scott Bessent reportedly calling a Chinese trade negotiator "disrespectful" and "unhinged" during remarks to Nikkei. This comes as China has sanctioned five U.S.-linked subsidiaries of South Korean shipbuilder Hanwha Ocean, a move the U.S. State Department views as an attempt to coerce South Korea and undermine U.S.-South Korea cooperation. The State Department criticized China's actions as an "irresponsible attempt to interfere with a private company's operations."
The economic fallout from these trade disputes is significant. A study highlighted by Axios projects that tariffs will cost U.S. firms $1.2 trillion in 2025, with the majority of this burden ultimately falling on consumers. Minneapolis Fed President Neel Kashkari acknowledged that tariffs "push up prices on goods we buy from abroad" and could slow down economic activity, making it difficult to gauge their full impact on inflation.
Fed Grapples with Inflation Amidst Economic Uncertainty
Federal Reserve officials are navigating a complex economic landscape. Minneapolis Fed President Neel Kashkari expressed concerns that the public remains worried about inflation, warning that prioritizing jobs over inflation control could harm workers in the long term. He also noted the difficulty in interpreting economic signals due to a government shutdown, which delays core government data. Kashkari expects services inflation to ease but cautioned that goods inflation could spill over as the job market slows.
Despite these challenges, Kashkari emphasized bipartisan support for the Federal Reserve's independence, welcoming the Supreme Court's May ruling that affirmed its unique status. He stressed that the Fed makes decisions based on data, not political considerations. Meanwhile, U.S. banks have reportedly tapped the Fed's lending facility, signaling short-term market strains as overnight rates climb. This was the largest daily borrowing from the Fed's Standing Repo Facility (SRF) since the pandemic, excluding quarter-end periods, indicating declining liquidity in the market.
Pharmaceutical Sector Reacts to Drug Pricing Pressures
The pharmaceutical industry faced headwinds as President Trump commented on drug pricing. Shares of Eli Lilly (LLY) and Novo Nordisk (NVO) fell in late trading after Trump suggested that the price of the widely used diabetes drug Ozempic could be reduced to as low as $150 a month. This follows earlier reports of Novo Nordisk already lowering Ozempic's price for cash-paying patients to $499 per month through its direct pharmacy service, partly in response to pressure from Trump and increased competition.
Safe-Haven Assets Surge on Global Jitters
In a clear sign of investor apprehension, gold and silver touched all-time highs. This surge was attributed to growing fears about credit quality in the economy and the heightened U.S.-China frictions, strengthening demand for these traditional safe-haven assets. Gold surpassed the $4,100 per ounce milestone for the first time, with analysts from Bank of America and Societe Generale now forecasting gold to reach $5,000 per ounce by 2026.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.